Sandia biochemist and virologist are conducting research using CRISPR-based technology to genetically engineer a deployable antiviral countermeasure for COVID- 19.
Their goal is to create an antiviral that will be customizable to respond to many different viruses, including coronavirus. Original public domain image from Flickr